ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas

Current Protocols in Immunology
Elena QuaglinoFederica Cavallo

Abstract

The epidermal growth factor receptor belongs to a superfamily of receptor tyrosine kinases (RTK) that includes ErbB2. ErbB2 is involved in normal physiological processes, such as embryogenesis, cell proliferation, differentiation, adhesion motility, and apoptosis, while its malfunction or overexpression is responsible for development defects, diabetes, and cancer. The human ortholog of ErbB2 is referred as Her-2 (human ErbB2) while the rat ortholog is referred as neu (rat ErbB2). As ErbB2 is directly involved in carcinogenesis, mice transgenic for the rat neu oncogene allow straightforward assessment of the ability of drugs and vaccines to inhibit the progression of neu-driven cancer. Information from this model may provide indications on the efficacy of similar treatments in patients. This commentary provides key information regarding the use of these transgenic mouse models for evaluation of the efficacy of anti-tumor strategies.

Citations

Sep 8, 2015·Vaccines·Pier-Luigi LolliniElena Quaglino
Jan 1, 2011·Cancers·Elena QuaglinoFederica Cavallo
Aug 18, 2010·International Journal of Cancer. Journal International Du Cancer·Kousaku MimuraRolf Kiessling
Mar 3, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sibylle GündischGianni Bussolati
Feb 20, 2013·Current Pathobiology Reports·Eric D Mortenson, Yang-Xin Fu
Sep 7, 2017·Cancer Immunology, Immunotherapy : CII·Mohammad W KhanKhashayarsha Khazaie
Mar 31, 2011·Proteomics. Clinical Applications·Regine M SchoenherrAmanda G Paulovich
May 3, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marco MacagnoFederica Cavallo
Jan 27, 2017·Oncoimmunology·Silvio BandiniFederica Cavallo
Oct 18, 2018·Cancer Immunology Research·Caterina BartolacciAugusto Amici
Apr 30, 2013·The American Journal of Pathology·Maddalena ArigoniElena Quaglino
Dec 3, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bart CornelissenKatherine A Vallis
Apr 5, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael MosleyBart Cornelissen
Jul 25, 2021·International Journal of Molecular Sciences·Abrar Ul Haq KhanYevgeniya Le

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis